Sign In
Buy ARQT
$21.35
+0.560 (+2.69%)
At Close: Jun 03, 2026
Arcutis Launches ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis
07:30am, Monday, 29'th Jul 2024
Once-daily, effective, safe, and well-tolerated ZORYVE cream now commercially available Provides rapid clearance of atopic dermatitis signs and symptoms and significant reduction in itch, and can be u
7 Biotech Stocks to Keep on Your Clinical Radar
02:57pm, Tuesday, 23'rd Jul 2024
Initially, I had every intention to write a cookie-cutter assessment of intriguing biotech stocks; that is, I wanted to say that enterprises within this specialized healthcare field will always be rel
Arcutis to Host ZORYVE® (Roflumilast) Cream 0.15% FDA Approval Call With KOL
08:00am, Monday, 22'nd Jul 2024
WESTLAKE VILLAGE, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in i
Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?
10:41am, Friday, 19'th Jul 2024
Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.
Arcutis (ARQT) Stock Rises 31% in the Past Month: Here's Why
10:57am, Wednesday, 17'th Jul 2024
Arcutis (ARQT) rises 30.9% in a month after the label expansion of its marketed product, Zoryve cream 0.15%, for the AD indication in adult and pediatric patients aged six years and older.
ZORYVE cream provides rapid relief, with efficacy, safety, and tolerability demonstrated up to 56 weeks of treatment ZORYVE cream rapidly and significantly reduces itch, the most bothersome symptom of
The 7 Best Under $10 Stocks to Buy in July 2024
08:00am, Saturday, 06'th Jul 2024
Savvy investors are discovering rewarding opportunities in some of the best stocks under $10 a share. Years ago, I found Advanced Micro Devices (NASDAQ: AMD ) at $10 a share and watched it rocket abov
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Wednesday, 03'rd Jul 2024
WESTLAKE VILLAGE, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in
Cheap Stocks To Buy: Gold Stock, Argentine Bank Near More Time For A Bullish Set-Up
07:15pm, Wednesday, 26'th Jun 2024
Himalaya Shipping also needs time to build a new good base.
Cheap Stocks To Buy: Is It Time To Buy This Ship Transport Leader?
07:15pm, Wednesday, 26'th Jun 2024
Banco BBVA has now made two tests of this key technical level in nearly three weeks.
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
09:25am, Friday, 21'st Jun 2024
We have narrowed our search to five small-cap biotech stocks with strong potential for the rest of 2024. These are: ARQT, BCYC, CSTL, PRME, LXRX.
Has Arcutis Biotherapeutics (ARQT) Outpaced Other Medical Stocks This Year?
10:46am, Monday, 17'th Jun 2024
Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 99.89%: Read This Before Placing a Bet
10:55am, Friday, 14'th Jun 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 99.9% in Arcutis Biotherapeutics (ARQT). While the effectiveness of this highly sought-after metric is question
Have $5-10? 7 Affordable Stocks That Are About to Breakout.
06:00am, Thursday, 13'th Jun 2024
Investors with any experience in the world of penny stocks know that risk is real. That risk is higher as the price of shares goes lower.
Investigational roflumilast cream 0.15% showed continued improvements in the signs and symptoms of AD, including itch, through 56 weeks of treatment 66.2% of participants treated with once-daily roflu
